Fig. 3From: TP53 mutation-mediated genomic instability induces the evolution of chemoresistance and recurrence in epithelial ovarian cancerAnalysis of TP53 mutations and DNA abnormalities. a: HE staining of the TP53 wild-type and mutant ovarian cancer cells to investigate nucleus morphology; b: quantitative analysis of the ovarian cancer cell DNA index in the TP53 wild-type and mutant groups; c: cell cycle analysis of polyploid cell ratios in two groups by flow cytometryBack to article page